Focused on building reliable datasets, financial models, and research tools for value-minded investors. Committed to turning complex data into practical guidance for value-investing and long-term wealth.
Dr. Charlie Tian is the founder and CEO of GuruFocus.com, a leading global investment research platform established in 2004. With a Ph.D. in physics, Dr. Tian transitioned from science to finance, applying a data-driven, disciplined approach to value investing.
Instil BioFRA:5GT0 31 Market Cap is €42.92 Mil as of Jul. 27, 2026. GuruFocus rates FRA:5GT0 with a GF Score™ of 31/100. The stock has 3 warning signs investors should review. Among 1,420 Biotechnology companies, Instil Bio ranks worse than 62.75% on this metric.
Market cap is the total market value to buy the whole company. It is equal to the share price times the number of Shares Outstanding (EOP). Instil Bio's share price for the quarter that ended in Mar. 2026 was €6.75. Instil Bio's Shares Outstanding (EOP) for the quarter that ended in Mar. 2026 was 6.78 Mil. Therefore, Instil Bio's market cap for the quarter that ended in Mar. 2026 was €45.78 Mil.
Instil Bio's quarterly market cap
increased
from Sep. 2025 (€0.00 Mil) to Dec. 2025 (€60.36 Mil) but then
declined
from Dec. 2025 (€60.36 Mil) to Mar. 2026 (€45.78 Mil).
Instil Bio's annual market cap
stayed the same
from Dec. 2023 (€0.00 Mil) to Dec. 2024 (€0.00 Mil) but then
increased
from Dec. 2024 (€0.00 Mil) to Dec. 2025 (€60.36 Mil).
Enterprise Value is the theoretical takeover price. It is more comprehensive than market capitalization (market cap), which only includes common equity. Enterprise Value is calculated as the market cap plus debt and minority interest and preferred shares, minus total cash and cash equivalents. Instil Bio's Enterprise Value for Today is €52.25 Mil.
Instil Bio (FRA:5GT0) Market Cap Explanation
Market cap is not the real price you pay for a company. If you buy the company and become its owner, you become the owner of the cash the company has, and you also assume the companys debt. The real price you pay is the Enterprise Value.
Warren Buffett uses the ratio of total market cap of all public traded companies over GDP to measure if the market is expensive. As of April 2012, the US total market cap is about $14.7 trillion, while the US GDP is about $15 trillion. The market was modestly overvalued.
Instil Bio Market Cap Related Terms
Instil Bio Market Cap Historical Data
* Premium members only.
The historical data trend for Instil Bio's Market Cap can be seen below:
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
FRA:5GT0 vs AURX, MCRB, DWTX: Market Cap Comparison
For the Biotechnology subindustry, Instil Bio's Market Cap, along with its competitors' market caps and Market Cap data, can be viewed below:
* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.
Instil Bio Market Cap vs Biotechnology Industry
For the Biotechnology industry and Healthcare sector, Instil Bio's Market Cap distribution charts can be found below:
* The bar in red indicates where Instil Bio's Market Cap falls into.
Market cap is the short version of market capitalization. It is the total market value to buy the whole company. It is equal to the share price times the number of shares outstanding.
Instil Bio's Market Cap for the fiscal year that ended in Dec. 2025 is calculated as
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
Instil Bio (FRA:5GT0) has a Market Cap of €42.92 Mil as of Jul. 27, 2026. Market cap equals the total value of a company's shares: price times shares outstanding. View historical data on Instil Bio and its competitors. According to the industry distribution chart, Instil Bio ranks #891 out of 1420 companies in the Biotechnology industry, placing it in the top 62.7%.
Is Instil Bio's Market Cap too high?
Instil Bio's current Market Cap is €42.92 Mil. Based on the distribution chart, Instil Bio ranks #891 out of 1420 companies in the Biotechnology industry, which is below the industry midpoint. Overall, Instil Bio has a GF Score™ of 31/100, reflecting its overall financial health beyond just this single metric.
How does Instil Bio's Market Cap compare to AURX and MCRB?
According to the Biotechnology industry distribution chart, Instil Bio ranks #891 out of 1420 companies for Market Cap. This places Instil Bio in the lower half of its industry. The industry median Market Cap is 110.66. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good Market Cap for a Biotechnology company?
The median Market Cap among Biotechnology companies is 110.66, based on 1,420 companies in the industry. Companies in the top quartile (top 25%) have a Market Cap significantly above this median, while those in the bottom quartile fall well below. However, Market Cap should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high Market Cap mean?
A high Market Cap can signal that a stock is expensive relative to its fundamentals. Market cap equals the total value of a company's shares: price times shares outstanding. View historical data on Instil Bio and its competitors. For the Biotechnology industry, the median Market Cap is 110.66 — values significantly above this may indicate overvaluation, while values below may suggest a bargain or underlying issues. Instil Bio's current Market Cap is €42.92 Mil. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is Instil Bio stock overvalued right now?
Instil Bio (FRA:5GT0) has a current Market Cap of €42.92 Mil. The current Market Cap is €42.92 Mil. Instil Bio's overall GF Score™ is 31/100 with 3 warning signs to review. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is Market Cap calculated?
Market Cap is calculated from a company's financial statements. For Instil Bio (FRA:5GT0), the current Market Cap is €42.92 Mil as of Jul. 27, 2026. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.
Instil Bio Inc is a clinical-stage biopharmaceutical company focused on developing a cell therapy pipeline of autologous tumor infiltrating lymphocyte, or TIL, therapies for the treatment of patients with cancer. It is also engaged in developing a novel class of genetically engineered TIL therapies using its Co-Stimulatory Antigen Receptor, or CoStAR, platform. Its pipeline includes ITIL-306 which expresses a CoStAR molecule designed to recognize, a tumor-associated antigen that is expressed on numerous solid tumors, including ovarian cancer, uterine cancer, NSCLC, and renal cancer.
31GF Score
Get the complete analysis for FRA:5GT0
Market Cap is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.
Quick Browse
Personalize
Premium Gurus 
Create New Portfolio
FRA:5GT0 has been successfully added to your 
